BMS teams with Alvin Ailey on dance promo

In an unorthodox pharma promotion, Alvin Ailey American Dance Theater, whose founder died of AIDS-related illnesses in 1989, is unveiling a new dance, "Home," sponsored by Bristol-Myers Squibb ($BMY). The maker of HIV drug Reyataz collected stories from HIV patients, and the dance theater used them as inspiration. Report | Release

Suggested Articles

Esperion's Nexletol has had a rough road to approval after safety concerns nearly derailed its quest. But an FDA nod has the drug ready for market.

The FDA approved Lundbeck's Vyepti, formerly known as eptinezumab, as the first IV therapy to prevent migraines in adults.

In an interview with Israel's Calcalist, Teva CEO Kåre Schultz shared details of his approach to the company's turnaround.